Literature DB >> 14565218

HIV-1 Vif: counteracting innate antiretroviral defenses.

Bryan R Cullen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565218     DOI: 10.1016/j.ymthe.2003.08.010

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  11 in total

1.  High-speed atomic force microscopy directly visualizes conformational dynamics of the HIV Vif protein in complex with three host proteins.

Authors:  Yangang Pan; Luda S Shlyakhtenko; Yuri L Lyubchenko
Journal:  J Biol Chem       Date:  2020-06-24       Impact factor: 5.157

2.  Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

Authors:  Yasumasa Iwatani; Hiroaki Takeuchi; Klaus Strebel; Judith G Levin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 3.  Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.

Authors:  Viviana Simon; Nicolin Bloch; Nathaniel R Landau
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

4.  Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1.

Authors:  Koichi Watashi; Mohammad Khan; Venkat R K Yedavalli; Man Lung Yeung; Klaus Strebel; Kuan-Teh Jeang
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

5.  APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.

Authors:  Rodolphe Suspène; Peter Sommer; Michel Henry; Stéphane Ferris; Denise Guétard; Sylvie Pochet; Ann Chester; Naveenan Navaratnam; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  Nucleic Acids Res       Date:  2004-04-30       Impact factor: 16.971

6.  A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice.

Authors:  Philip H Jones; Harshini V Mehta; Chioma M Okeoma
Journal:  Retrovirology       Date:  2012-06-12       Impact factor: 4.602

7.  Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family.

Authors:  Mayumi Imahashi; Masaaki Nakashima; Yasumasa Iwatani
Journal:  Front Microbiol       Date:  2012-07-09       Impact factor: 5.640

8.  Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.

Authors:  Viviana Simon; Veronique Zennou; Deya Murray; Yaoxing Huang; David D Ho; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2005-07-22       Impact factor: 6.823

9.  Catalytic analysis of APOBEC3G involving real-time NMR spectroscopy reveals nucleic acid determinants for deamination.

Authors:  Keisuke Kamba; Takashi Nagata; Masato Katahira
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

10.  Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.

Authors:  Anjie Zhen; Juan Du; Xiaohong Zhou; Yong Xiong; Xiao-Fang Yu
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.